Dr Martin Johnston
- Honorary Clinical Associate Professor (School of Cardiovascular & Metabolic Health)
Publications
2022
McGettrick, M., Dormand, H., Brewis, M., Johnson, M. K., Lang, N. N. and Church, A. C. (2022) Cardiac geometry, as assessed by cardiac magnetic resonance, can differentiate subtypes of chronic thromboembolic pulmonary vascular disease. Frontiers in Cardiovascular Medicine, 9, 1004169. (doi: 10.3389/fcvm.2022.1004169) (PMID:36582741) (PMCID:PMC9793745)
Stubbs, H., Brewis, M., Church, C. and Johnson, M. (2022) Towards telemedicine in pulmonary hypertension: assessing the feasibility of remote quality of life and exercise capacity assessment. Pulmonary Circulation, 12(4), e12144. (doi: 10.1002/pul2.12144) (PMID:36381292) (PMCID:PMC9647124)
Stubbs, H., MacLellan, A., McGettrick, M., Jani, B. , Brewis, M., Church, C. and Johnson, M. (2022) Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland. Open Heart, 9(1), e002023. (doi: 10.1136/openhrt-2022-002023) (PMID:35477699) (PMCID:PMC9047890)
2021
McGettrick, M., MacLellan, A., McCaughey, P., Bagot, C., Brewis, M.J., Lang, N.N. , Johnson, M.K. and Church, A.C. (2021) Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in Scotland. BMJ Open, 11, e050281. (doi: 10.1136/bmjopen-2021-050281) (PMID:34462282)
2020
Wilson, K. S. et al. (2020) Apoptosis signal-regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension. Pulmonary Circulation, 10(2), (doi: 10.1177/2045894020922810)
Peacock, A. J. et al. (2020) Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype? Pulmonary Circulation, 10(1), pp. 1-8. (doi: 10.1177/2045894020914851)
2019
McCall, P. J. , Arthur, A., Glass, A., Corcoran, D. S., Kirk, A., Macfie, A., Payne, J., Johnson, M., Kinsella, J. and Shelley, B. G. (2019) The right ventricular response to lung resection. Journal of Thoracic and Cardiovascular Surgery, 158(2), 556-565.e5. (doi: 10.1016/j.jtcvs.2019.01.067) (PMID:30826095)
2018
Panagiotou, M., Vogiatzis, I., Jayasekera, G., Louvaris, Z., Mackenzie, A., Mcglinchey, N., Baker, J. S., Church, A. C., Peacock, A. J. and Johnson, M. K. (2018) Validation of impedance cardiography in pulmonary arterial hypertension. Clinical Physiology and Functional Imaging, 38(2), pp. 254-260. (doi: 10.1111/cpf.12408) (PMID:28168802)
2017
Sithamparanathan, S. et al. (2017) Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry. Journal of Heart and Lung Transplantation, 36(7), pp. 770-779. (doi: 10.1016/j.healun.2016.12.014) (PMID:28190786)
2014
Qureshi, M. U., Vaughan, G. D.A., Sainsbury, C., Johnson, M., Peskin, C. S., Olufsen, M. S. and Hill, N.A. (2014) Numerical simulation of blood flow and pressure drop in the pulmonary arterial and venous circulation. Biomechanics and Modeling in Mechanobiology, 13(5), pp. 1137-1154. (doi: 10.1007/s10237-014-0563-y) (PMID:24610385) (PMCID:PMC4183203)
Articles
McGettrick, M., Dormand, H., Brewis, M., Johnson, M. K., Lang, N. N. and Church, A. C. (2022) Cardiac geometry, as assessed by cardiac magnetic resonance, can differentiate subtypes of chronic thromboembolic pulmonary vascular disease. Frontiers in Cardiovascular Medicine, 9, 1004169. (doi: 10.3389/fcvm.2022.1004169) (PMID:36582741) (PMCID:PMC9793745)
Stubbs, H., Brewis, M., Church, C. and Johnson, M. (2022) Towards telemedicine in pulmonary hypertension: assessing the feasibility of remote quality of life and exercise capacity assessment. Pulmonary Circulation, 12(4), e12144. (doi: 10.1002/pul2.12144) (PMID:36381292) (PMCID:PMC9647124)
Stubbs, H., MacLellan, A., McGettrick, M., Jani, B. , Brewis, M., Church, C. and Johnson, M. (2022) Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland. Open Heart, 9(1), e002023. (doi: 10.1136/openhrt-2022-002023) (PMID:35477699) (PMCID:PMC9047890)
McGettrick, M., MacLellan, A., McCaughey, P., Bagot, C., Brewis, M.J., Lang, N.N. , Johnson, M.K. and Church, A.C. (2021) Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in Scotland. BMJ Open, 11, e050281. (doi: 10.1136/bmjopen-2021-050281) (PMID:34462282)
Wilson, K. S. et al. (2020) Apoptosis signal-regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension. Pulmonary Circulation, 10(2), (doi: 10.1177/2045894020922810)
Peacock, A. J. et al. (2020) Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype? Pulmonary Circulation, 10(1), pp. 1-8. (doi: 10.1177/2045894020914851)
McCall, P. J. , Arthur, A., Glass, A., Corcoran, D. S., Kirk, A., Macfie, A., Payne, J., Johnson, M., Kinsella, J. and Shelley, B. G. (2019) The right ventricular response to lung resection. Journal of Thoracic and Cardiovascular Surgery, 158(2), 556-565.e5. (doi: 10.1016/j.jtcvs.2019.01.067) (PMID:30826095)
Panagiotou, M., Vogiatzis, I., Jayasekera, G., Louvaris, Z., Mackenzie, A., Mcglinchey, N., Baker, J. S., Church, A. C., Peacock, A. J. and Johnson, M. K. (2018) Validation of impedance cardiography in pulmonary arterial hypertension. Clinical Physiology and Functional Imaging, 38(2), pp. 254-260. (doi: 10.1111/cpf.12408) (PMID:28168802)
Sithamparanathan, S. et al. (2017) Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry. Journal of Heart and Lung Transplantation, 36(7), pp. 770-779. (doi: 10.1016/j.healun.2016.12.014) (PMID:28190786)
Qureshi, M. U., Vaughan, G. D.A., Sainsbury, C., Johnson, M., Peskin, C. S., Olufsen, M. S. and Hill, N.A. (2014) Numerical simulation of blood flow and pressure drop in the pulmonary arterial and venous circulation. Biomechanics and Modeling in Mechanobiology, 13(5), pp. 1137-1154. (doi: 10.1007/s10237-014-0563-y) (PMID:24610385) (PMCID:PMC4183203)